Journal of Autism and Developmental Disorders · 2021 · 40 citations · 70 references
MedicineHealth PolicyAutism Spectrum DisordersDisease PreventionEpidemiologyDisease Prevention PolicyNeurodevelopmental DisordersNeurodevelopmental EpidemiologyCensus-based ProjectionsCost-effectiveness Of PreventionHigh-cost Illness ImpactPreventive Care CostsProbabilistic Population Projections
The cost of ASD in the U.S. is estimated using a forecast model that for the first time accounts for the true historical increase in ASD. Model inputs include ASD prevalence, census population projections, six cost categories, ten age brackets, inflation projections, and three future prevalence scenarios. Future ASD costs increase dramatically: total base-case costs of $223 (175-271) billion/year are estimated in 2020; $589 billion/year in 2030, $1.36 trillion/year in 2040, and $5.54 (4.29-6.78) trillion/year by 2060, with substantial potential savings through ASD prevention. Rising prevalence, the shift from child to adult-dominated costs, the transfer of costs from parents onto government, and the soaring total costs raise pressing policy questions and demand an urgent focus on prevention strategies.
70
Jon Baio, Lisa D. Wiggins, Deborah Christensen et al. · MMWR Surveillance Summaries · 2018 · 5.5K citations · Full text
Morbidity and mortality weekly report
The American Journal of Medicine · 1997 · 4.7K citations
Matthew J. Maenner, Kelly Shaw, Jon Baio et al. · MMWR Surveillance Summaries · 2020 · 3.9K citations · Full text
Medicine, Child Health, Pediatrics +11
Deborah Christensen, Jon Baio, Kim Van Naarden Braun et al. · MMWR Surveillance Summaries · 2016 · 2K citations · Full text